S&P 500 7,323.63 −0.23%
Nasdaq 24,429.89 +0.42%
S&P/TSX 34,578.05 −2.09%
Apple 352.45 +0.15%
Nvidia 150.96 −2.89%
Microsoft 508.29 +0.40%
Shopify 199.78 −1.50%
Royal Bank 272.26 −3.11%
CAD/USD 0.6993 −0.01%
PRE-MKT · 05:50 ET
Market ClerkRecap
Thu Nov 19 · pre-market7 signals on Nov 18520 insider buys this week · $248.1MCIRO short report next: Nov 30The week ahead

TSHA

Taysha Gene Therapies, Inc.
NASDAQ · HEALTH CARE · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
3.99
−0.01 −0.25%
USD · close Nov 18

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $1.3BP/E —DIV YIELD —FCF YIELD -10.20%REV TTM $5.5M −32.3%NET INCOME −$149.6MNET CASH $417.1M52W 3.51 – 6.98SEC XBRL · TTM TO Invalid Date

Congress is trading it

STOCK ACT DISCLOSURES
No STOCK Act disclosure names TSHA.

The STOCK Act allows 45 days to disclose; a lag over that is shown in red. Amounts are the ranges members report. Every member, every trade.

Watch TSHA. Know when insiders buy.
One email the day a filing lands. Free.